Integrating AI Agents, Robotics and Digital Twins to Accelerate the Rise of AI-Native Healthcare Infrastructure
【Taipei, Taiwan — June 1, 2026】Foxconn (TWSE: 2317) today unveiled its latest Physical AI healthcare vision at COMPUTEX 2026 and NVIDIA GTC Taipei 2026, showcasing how AI agents, collaborative robotics, digital twins and multimodal medical AI are converging to transform real-world hospital operations and accelerate the emergence of next-generation smart hospitals.
At a featured session held at the Taipei International Convention Center (TICC), Foxconn B Group President Barry Chiang joined Digital Health User Experience Design Director Alice Lin to present “Empowering Healthcare with Embodied Intelligence: From Nurabot Deployment to Smart Hospital Workflow Transformation.” The session highlighted how Foxconn is leveraging NVIDIA accelerated computing, simulation platforms and AI technologies to bring Physical AI from simulation into real-world clinical environments.
As healthcare systems worldwide confront aging populations, workforce shortages and growing clinical complexity, Foxconn is advancing a next-generation healthcare AI ecosystem built upon AI infrastructure, multimodal medical models, embodied intelligence and clinical workflow orchestration. Rather than developing isolated AI tools, Foxconn is integrating AI systems capable of perceiving, reasoning and acting alongside healthcare professionals across hospital environments.
Built upon NVIDIA’s “Five-Layer Cake” full-stack AI architecture spanning Energy, Infrastructure, Platform, Models and Applications, Foxconn showcased multiple healthcare innovations powered by technologies including NVIDIA Omniverse, NVIDIA Isaac, NVIDIA Holoscan, MONAI, NVIDIA Nemotron and NVIDIA NemoClaw. Together, these technologies enable the development of AI-native healthcare infrastructure designed to support increasingly autonomous, intelligent and real-world clinical operations.
Among the highlights was Nurabot, Foxconn’s nursing collaborative robot, which completed field validation last year and is now progressively expanding into hospitals and long-term care environments, including Taipei Veterans General Hospital, Tungs’ Taichung MetroHarbor Hospital, as well as overseas nursing education institutions. Real-world deployment data shows Nurabot can execute 75–80 tasks daily and help reduce nursing workload by approximately 30% through medication delivery, specimen transport and other clinical assistance workflows.
Foxconn also showcased its scrub nurse collaborative robot, jointly developed with Kawasaki Heavy Industries, Taichung Veterans General Hospital and Yuan High-Tech. The system leverages the NVIDIA Isaac for Healthcare Agent-Ready Rheo Blueprint alongside NVIDIA Isaac GR00T Vision-Language-Action (VLA) architecture to enable multimodal perception, surgical scene understanding and intelligent task reasoning.
Since its debut at GTC earlier this year, the project has achieved significant progress in simulation training and surgical workflow validation, with future clinical validation planned to accelerate the development of intelligent human-robot collaboration inside operating rooms.
Another major showcase was Foxconn’s “Integrated Chemotherapy Drug Compounding and Delivery System for Smart Hospital Automation,” jointly developed with Taipei Veterans General Hospital, Kawasaki Heavy Industries, Yuyama Manufacturing and FARobot. Built upon real clinical workflows at Taipei Veterans General Hospital, the platform integrates chemotherapy drug compounding, autonomous intra-hospital transport and nursing delivery into a unified intelligent workflow. Powered by NVIDIA Omniverse, the system creates a virtual-physical integrated healthcare environment in which ChemoRo performs high-precision chemotherapy drug compounding, FARobot SMR30 autonomously transports medications within the hospital, and Nurabot supports last-mile delivery to nursing stations and patients.
Together, the platform establishes a closed-loop workflow spanning compounding, transport and administration — helping improve operational efficiency, reduce manual workloads and enhance medication safety, traceability and process reliability in high-risk healthcare environments.
Foxconn also introduced CoDoClaw, a clinical intelligent agent system built on NVIDIA NemoClaw, an open source blueprintfor deploying autonomous agents, like OpenClaw, with NVIDIA OpenShell for added privacy and security controls . Riding the rapid rise of agentic AI, CoDoClaw advances CoDoctor AI from standalone AI tools into a Multi-Agent Orchestration platform capable of coordinating AI agents across breast cancer screening, ECG analysis, fundus imaging and coronary artery analysis through a unified clinical interface.
By connecting AI-driven lesion detection, appointment scheduling, report generation and follow-up management, CoDoClaw demonstrates how clinical AI agents can progressively support cross-department workflow orchestration and future healthcare automation. Foxconn envisions CoDoClaw as a foundational orchestration layer for future AI-native hospitals, enabling medical AI agents, robotics systems and clinical workflows to coordinate through shared operational intelligence.
“Healthcare’s next transformation will not come from AI models alone, but from AI systems capable of perceiving, reasoning and acting in real-world clinical environments alongside healthcare professionals,” said Barry Chiang, President of Foxconn B Group and Digital Health. “Foxconn is building the next generation of intelligent healthcare through AI infrastructure, digital twins, embodied intelligence and ecosystem collaboration. We believe Physical AI will fundamentally reshape how hospitals operate and how care is delivered in the future.”
Taiwan offers unique advantages for advancing smart healthcare and sovereign AI, combining world-class healthcare and national insurance systems, global leadership in semiconductors and AI infrastructure, and highly integrated clinical environments. Taiwan’s highly digitized healthcare ecosystem also provides an ideal real-world environment for validating Physical AI deployment and sovereign healthcare AI at scale. Through collaboration across government, hospitals and industry, Taiwan has the opportunity not only to address its own healthcare challenges, but also to help shape new operational models for intelligent healthcare worldwide.
Moving forward, Foxconn will continue working with NVIDIA and ecosystem partners through the Taiwan Digital Health Alliance (HiMEDt) to accelerate Physical AI deployment across hospitals, long-term care and home healthcare environments, helping position Taiwan as a global showcase for next-generation smart healthcare transformation.



